Dr Reddy's Laboratories Ltd
BSE:500124
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dr Reddy's Laboratories Ltd
BSE:500124
|
IN |
|
B
|
Bank of America Corp
XHAN:NCB
|
US |
|
D
|
Dillard's Inc
XMUN:DL7A
|
US |
|
E
|
Enbridge Inc
XMUN:EN3
|
CA |
|
B
|
Bureau Veritas SA
XMUN:4BV
|
FR |
|
M
|
Meituan
SWB:9MD
|
CN |
|
T
|
Travelers Companies Inc
BMV:TRV
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DRREDDY's stock price target?
Price Target
1 240.61
INR
According to Wall Street analysts, the average 1-year price target for 
DRREDDY is 1 240.61 INR with a low forecast of 1 045.34 INR and a high forecast of 1 819.95 INR.
What is the Revenue forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is 8%.
What is the Gross Profit forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 5 years is 6%.
What is the Operating Income forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 5 years is 17%.
What is the Pre-Tax Income forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 7%. The projected CAGR for the next 3 years is 12%.
What is the Net Income forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 5 years is 16%.